KANTAR HEALTH BLOG

kh_blog_hero_1600px
  • It’s lobbying, Jim, but not as we know it

    by Mark Sales  |  Nov 16, 2016
    Reputation is something that has always been close to our hearts in healthcare, an industry often derided by many (including my non-pharma friends) as “evil,” yet the numbers tell a different story.
  • Quidditch, the Olympics and building a brand

    by Mark Sales  |  Aug 18, 2016
    From a branding perspective I find the Olympics fascinating: No overt sponsorship within the actual games apart from kit manufacturers’ logos discreetly placed uniforms, yet London 2012 reached 76% of people on the planet with access to a TV. The brand that benefits (or loses) the most seems to me to be the country in which it was hosted.
  • Commercial effectiveness in real life

    by Ales Tichopad  |  Mar 22, 2016
    An interview with Vladislav Urda, Commercial Excellence Director Europe at Teva Pharmaceuticals, about the importance of commercial effectiveness activities in his business.
  • It’s just not cricket

    by Mark Sales  |  Feb 26, 2016
    We have played at the edge of patient (and consumers who are at risk of becoming patients) data for far too long.
  • Laugh along with the common people

    by Mark Sales  |  Dec 3, 2015
    Emotional positioning as part of the marketing mix is getting ever more important in healthcare, especially as masterful use of multiple channels can connect healthcare professionals and patients to your brand very powerfully.
Page